Index · 1 ranked
Funds Tracking the Biotech
Ranked by expense ratio, lowest first.
Data as of May 31, 2026 ·How this data is built
As of May 31, 2026, FundVersus ranks 1 funds tracking the Biotech by expense ratio. The lowest is VanEck Biotech ETF (BBH) at 0.35%. The median is 0.35%; weighted by assets, 0.35%.
Facts from SEC filings. Not investment advice.
The ranking
Only the stated measure sets the order. Expense ratios from prospectuses; net assets and returns from Form N-PORT.
| # | Fund | Expense ratio | Net assets | 1-year return | |
|---|---|---|---|---|---|
| 1 | VanEck Biotech ETFBBH · ETF · Health Care | 0.35% | $372M | +20.10% |
Questions
How is this list ranked?
Ranked by expense ratio, lowest first. It includes funds tracking the Biotech with a current SEC filing and enough data for a FundVersus page. The ranking uses one stated measure and is not a recommendation.
Which has the lowest expense ratio?
VanEck Biotech ETF (BBH), at 0.35% as of May 31, 2026.
How much money is in these funds?
The 1 funds on this list reported $372M in combined net assets on their latest filings.